339
Views
4
CrossRef citations to date
0
Altmetric
Health Economics

Concomitant Asthma Medication Use in Patients Receiving Omalizumab: Results from Three Large Insurance Claims Databases

, M.A., , M.Ph., Sc.D., , Ph.D., , Pharm.D., , Ph.D., , M.S., Ph.D. & , M.A. show all
Pages 923-930 | Published online: 07 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephanie Chen, Sarowar Golam, Julie Myers, Chris Bly, Harry Smolen & Xiao Xu. (2018) Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion 34:12, pages 2075-2088.
Read now

Articles from other publishers (3)

Alexandrosz Czira, Monica Turner, Amber Martin, David Hinds, Helen Birch, Frances Gardiner & Shiyuan Zhang. (2022) A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma. Respiratory Medicine 191, pages 106670.
Crossref
Abhishek Kavati, Maryia Zhdanava, Benjamin Ortiz, Jason Lecocq, Bradd Schiffman, Dominic Pilon, Harriet Ho, Patrick Lefebvre & Brian Stone. (2019) Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma. Clinical Therapeutics 41:10, pages 1956-1971.
Crossref
Hubert Chen, Mark D. Eisner, Tmirah Haselkorn & Benjamin Trzaskoma. (2013) Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab. Respiratory Medicine 107:1, pages 60-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.